DALYs of head and neck cancer in 1990 and 2021, and their average annual percentage changes among five GBD subregions within Asia from 1990 to 2021. by Mengjuan Ding (21560393)

Subjects:

DALYs and ASDR of larynx cancer in 2021, and their average annual percentage changes from 1990 to 2021. by Mengjuan Ding (21560393)

Subjects:

Joinpoint analysis of trends in the age-standardized DALYs rates of HNC, NPC, and TC from 1990 to 2021. by Mengjuan Ding (21560393)

Subjects:

DALYs and ASDR of nasopharynx cancer in 2021, and their average annual percentage changes from 1990 to 2021. by Mengjuan Ding (21560393)

Subjects:

Odds ratios and 95% confidence intervals of micronutrient intakes below the estimated average requirement (EAR) in men according to frailty groups. by Subeen Kim (11714313)

Subjects:

Least-squares means (95% confidence intervals) of daily nutrient intake of study participants in men according to frailty groups. by Subeen Kim (11714313)

Subjects:

Odds ratios and 95% confidence intervals of micronutrient intakes below the estimated average requirement (EAR) in women according to frailty groups. by Subeen Kim (11714313)

Subjects:

Characteristics of study participants in men according to frailty groups. by Subeen Kim (11714313)

Subjects:

Percentage of participants with micronutrient intakes below the estimated average requirement (EAR) by frailty groups. by Subeen Kim (11714313)

Subjects:

Least-squares means (95% confidence intervals) of daily nutritional intake of study participants in women according to Frailty Groups. by Subeen Kim (11714313)

Subjects:

Flowchart of the study participants. by Subeen Kim (11714313)

Subjects:

Characteristics of study participants in women according to frailty groups. by Subeen Kim (11714313)

Subjects:

Percentage of macronutrient intake relative to the acceptable macronutrient distribution range (AMDR) by frailty groups. by Subeen Kim (11714313)

Subjects:

Basic characteristics of the study participants by gender. by Subeen Kim (11714313)

Subjects:

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

“…<b>(D)</b> Similarly, U251MG cells showed significantly decreased clonogenic potential upon 100ΜM SHG-44 treatment when compared to 100ΜM cis-platin and the untreated control. …”

Significant condition. by Junxia Zhou (14381598)

Subjects:

Burden and trends of LC in the chinese annual cancer registry in 2004 and 2018. by Ze-Xing Zhang (18074512)

Subjects:

EAPC in incidence and mortality of LC for age group. by Ze-Xing Zhang (18074512)

Subjects:

Cases and deaths of LC from the Chinese Annual Cancer Registry, 2004–2018. by Ze-Xing Zhang (18074512)

Subjects:

Changes in LC cases and deaths in male and female from 2004 to 2018, decomposed by three population-level determinants: population aging, population growth and epidemiological chan... by Ze-Xing Zhang (18074512)

Subjects: